TP53 and colorectal carcinoma: Taken together, our results underscore the capacity of PRIMA‐1met to synergistically interact with L‐OHP against CRC cells, effectively resensitizing L‐OHP‐resistant p53‐mutant CRC cells to L‐OHP.